This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, et al. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 2012; 227: 44-58. doi: 10.1002/jcp.22724CarboneMLyBHDodsonRFPaganoIMorrisPTDoganUAet alMalignant mesothelioma: facts, myths, and hypothesesJ Cell Physiol201222744–5810.1002/jcp.22724314320621412769Open DOISearch in Google Scholar
Linton A, Vardy J, Clarke S, van Zandwijk N. The ticking time-bomb of asbestos: its insidious role in the development of malignant mesothelioma. Crit Rev Oncol Hematol 2012; 84: 200-12. doi: 10.1016/j.critrevonc.2012.03.001LintonAVardyJClarkeSvan Zandwijk N. The ticking time-bomb of asbestos: its insidious role in the development of malignant mesotheliomaCrit Rev Oncol Hematol201284200–1210.1016/j.critrevonc.2012.03.00122459593Open DOISearch in Google Scholar
Franko A, Kotnik N, Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V. The influence of genetic variability on the risk of developing malignant mesothelioma. Radiol Oncol 2018; 52: 105-11. doi: 10.2478/raon-2018-0004FrankoAKotnikNGoricarKKovacVDodic-FikfakMDolzanVThe influence of genetic variability on the risk of developing malignant mesotheliomaRadiol Oncol201852105–1110.2478/raon-2018-0004583908829520212Open DOISearch in Google Scholar
Remon J, Lianes P, Martinez S, Velasco M, Querol R, Zanui M. Malignant mesothelioma: new insights into a rare disease. Cancer Treat Rev 2013; 39: 584-91. doi: 10.1016/j.ctrv.2012.12.005RemonJLianesPMartinezSVelascoMQuerolRZanuiMMalignant mesothelioma: new insights into a rare diseaseCancer Treat Rev201339584–9110.1016/j.ctrv.2012.12.00523276688Open DOISearch in Google Scholar
Franko A, Dolzan V, Kovac V, Arneric N, Dodic-Fikfak M. Soluble mesothelinrelated peptides levels in patients with malignant mesothelioma. Dis Markers 2012; 32: 123-31. doi: 10.3233/DMA-2011-0866FrankoADolzanVKovacVArnericNDodic-FikfakMSoluble mesothelinrelated peptides levels in patients with malignant mesotheliomaDis Markers201232123–3110.3233/DMA-2011-0866382670522377706Open DOISearch in Google Scholar
Weiner SJ, Neragi-Miandoab S. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors. J Cancer Res Clin Oncol 2009; 135: 15-27. doi: 10.1007/s00432-008-0444-9WeinerSJNeragi-MiandoabSPathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factorsJ Cancer Res Clin Oncol200913515–2710.1007/s00432-008-0444-918787841Open DOISearch in Google Scholar
Zellos L, Christiani DC. Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin 2004; 14: 469-77, viii. doi: 10.1016/j. thorsurg.2004.06.011ZellosLChristianiDCEpidemiology, biologic behavior, and natural history of mesotheliomaThorac Surg Clin200414469–77viii. doi10.1016/j.thorsurg.2004.06.01115559053Open DOISearch in Google Scholar
Sen D. Working with asbestos and the possible health risks. Occup Med (Lond) 2015; 65: 6-14. doi: 10.1093/occmed/kqu175SenDWorking with asbestos and the possible health risksOccup Med (Lond)2015656–1410.1093/occmed/kqu17525559791Open DOISearch in Google Scholar
Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health 2007; 45: 379-87. doi: 10.2486/ indhealth.45.379BianchiCBianchiTMalignant mesothelioma: global incidence and relationship with asbestosInd Health200745379–8710.2486/indhealth.45.37917634686Open DOISearch in Google Scholar
Case BW, Abraham JL, Meeker G, Pooley FD, Pinkerton KE. Applying definitions of “asbestos” to environmental and “low-dose” exposure levels and health effects, particularly malignant mesothelioma. J Toxicol Environ Health B Crit Rev 2011; 14: 3-39. doi: 10.1080/10937404.2011.556045CaseBWAbrahamJLMeekerGPooleyFDPinkertonKEApplying definitions of “asbestos” to environmental and “low-dose” exposure levels and health effects, particularly malignant mesotheliomaJ Toxicol Environ Health B Crit Rev2011143–3910.1080/10937404.2011.556045311848721534084Open DOISearch in Google Scholar
Toyokuni S. Mechanisms of asbestos-induced carcinogenesis. Nagoya J Med Sci 2009; 71: 1-10. doi: 10.1265/jjh.66.562ToyokuniSMechanisms of asbestos-induced carcinogenesisNagoya J Med Sci2009711–1010.1265/jjh.66.562Open DOISearch in Google Scholar
Upadhyay D, Kamp DW. Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis. Exp Biol Med (Maywood) 2003; 228: 650-9. doi: 10.1177/153537020322800602UpadhyayDKampDWAsbestos-induced pulmonary toxicity: role of DNA damage and apoptosisExp Biol Med (Maywood)2003228650–910.1177/153537020322800602Open DOISearch in Google Scholar
Manning CB, Vallyathan V, Mossman BT. Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2002; 2: 191-200. doi: 10.1016/S1567-5769(01)00172-2ManningCBVallyathanVMossmanBTDiseases caused by asbestos: mechanisms of injury and disease developmentInt Immunopharmacol20022191–20010.1016/S1567-5769(01)00172-2Open DOISearch in Google Scholar
Dianzani I, Gibello L, Biava A, Giordano M, Bertolotti M, Betti M, et al. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat Res 2006; 599: 124-34. doi: 10.1016/j.mrfmmm.2006.02.005DianzaniIGibelloLBiavaAGiordanoMBertolottiMBettiMet alPolymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population studyMutat Res2006599124–3410.1016/j.mrfmmm.2006.02.00516564556Open DOISearch in Google Scholar
Betti M, Ferrante D, Padoan M, Guarrera S, Giordano M, Aspesi A, et al. XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study. Mutat Res 2011; 708: 11-20. doi: 10.1016/j.mrfmmm.2011.01.001BettiMFerranteDPadoanMGuarreraSGiordanoMAspesiAet alXRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control studyMutat Res201170811–2010.1016/j.mrfmmm.2011.01.00121277872Open DOISearch in Google Scholar
Spivak G. Nucleotide excision repair in humans. DNA Repair (Amst) 2015; 36: 13-8. doi: 10.1016/j.dnarep.2015.09.003SpivakGNucleotide excision repair in humansDNA Repair (Amst)20153613–810.1016/j.dnarep.2015.09.003468807826388429Open DOISearch in Google Scholar
Zhang L, Wang J, Xu L, Zhou J, Guan X, Jiang F, et al. Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis. Mutagenesis 2012; 27: 67-76. doi: 10.1093/mutage/ger062ZhangLWangJXuLZhouJGuanXJiangFet alNucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysisMutagenesis20122767–7610.1093/mutage/ger06222002622Open DOISearch in Google Scholar
Zhao Z, Zhang A, Zhao Y, Xiang J, Yu D, Liang Z, et al. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility. Biosci Rep 2018; 38(3): BSR20180114. doi: 10.1042/BSR20180114ZhaoZZhangAZhaoYXiangJYuDLiangZet alThe association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibilityBiosci Rep2018383BSR2018011410.1042/BSR20180114601370829669843Open DOISearch in Google Scholar
Manandhar M, Boulware KS, Wood RD. The ERCC1 and ERCC4 (XPF) genes and gene products. Gene 2015; 569: 153-61. doi: 10.1016/j. gene.2015.06.026ManandharMBoulwareKSWoodRDThe ERCC1 and ERCC4 (XPF) genes and gene productsGene2015569153–6110.1016/j.gene.2015.06.026453607426074087Open DOISearch in Google Scholar
Ding YW, Gao X, Ye DX, Liu W, Wu L, Sun HY. Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studies. Clin Transl Oncol 2015; 17: 710-9. doi: 10.1007/s12094-015-1298-7DingYWGaoXYeDXLiuWWuLSunHYAssociation of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studiesClin Transl Oncol201517710–910.1007/s12094-015-1298-726022132Open DOISearch in Google Scholar
Li B, Shi X, Yuan Y, Peng M, Jin H, Qin D. ERCC1 rs11615 polymorphism increases susceptibility to breast cancer: a meta-analysis of 4547 individuals. Biosci Rep 2018; 38(3): BSR20180440. doi: 10.1042/BSR20180440LiBShiXYuanYPengMJinHQinDERCC1 rs11615 polymorphism increases susceptibility to breast cancer: a meta-analysis of 4547 individualsBiosci Rep2018383BSR2018044010.1042/BSR20180440Open DOISearch in Google Scholar
Chen J, Sun N, Hu G, Chen X, Jiang J, Wu H, et al. Association of ERCC1 polymorphisms with the risk of colorectal cancer: a meta-analysis. Crit Rev Eukaryot Gene Expr 2017; 27(3): 267-75. doi: 10.1615/ CritRevEukaryotGeneExpr.2017019713ChenJSunNHuGChenXJiangJWuHet alAssociation of ERCC1 polymorphisms with the risk of colorectal cancer: a meta-analysisCrit Rev Eukaryot Gene Expr2017273267–7510.1615/CritRevEukaryotGeneExpr.2017019713Open DOISearch in Google Scholar
De Mattia E, Cecchin E, Polesel J, Bignucolo A, Roncato R, Lupo F, et al. Genetic biomarkers for hepatocellular cancer risk in a caucasian population. World J Gastroenterol 2017; 23: 6674-84. doi: 10.3748/wjg.v23.i36.6674De MattiaECecchinEPoleselJBignucoloARoncatoRLupoFet alGenetic biomarkers for hepatocellular cancer risk in a caucasian populationWorld J Gastroenterol2017236674–8410.3748/wjg.v23.i36.6674Open DOISearch in Google Scholar
London RE. The structural basis of XRCC1-mediated DNA repair. DNA repair. 2015; 30: 90-103. doi: 10.1016/j.dnarep.2015.02.005LondonREThe structural basis of XRCC1-mediated DNA repairDNA repair20153090–10310.1016/j.dnarep.2015.02.005Open DOISearch in Google Scholar
Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2003; 2: 901-8. doi: 10.1016/S1568-7864(03)00085-5WangYSpitzMRZhuYDongQSheteSWuXFrom genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivityDNA Repair (Amst)20032901–810.1016/S1568-7864(03)00085-5Open DOISearch in Google Scholar
Srivastava A, Srivastava K, Pandey SN, Choudhuri G, Mittal B. Singlenucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population. Ann Surg Oncol 2009; 16: 1695-703. doi: 10.1245/s10434-009-0354-3SrivastavaASrivastavaKPandeySNChoudhuriGMittalBSinglenucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian populationAnn Surg Oncol2009161695–70310.1245/s10434-009-0354-319266243Open DOISearch in Google Scholar
Jafari Nedooshan J, Forat Yazdi M, Neamatzadeh H, Zare Shehneh M, Kargar S, Seddighi N. Genetic association of XRCC1 gene rs1799782, rs25487 and rs25489 polymorphisms with risk of thyroid cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev 2017; 18: 263-70. doi: 10.22034/ APJCP.2017.18.1.263JafariNedooshan JForatYazdi MNeamatzadehHZareShehneh MKargarSSeddighiNGenetic association of XRCC1 gene rs1799782, rs25487 and rs25489 polymorphisms with risk of thyroid cancer: a systematic review and meta-analysisAsian Pac J Cancer Prev201718263–7010.22034/APJCP.2017.18.1.263556311128240845Open DOISearch in Google Scholar
Zhu DQ, Zou Q, Hu CH, Su JL, Zhou GH, Liu P. XRCC1 genetic polymorphism acts a potential biomarker for lung cancer. Tumour Biol 2015; 36: 3745-50. doi: 10.1007/s13277-014-3014-6ZhuDQZouQHuCHSuJLZhouGHLiuPXRCC1 genetic polymorphism acts a potential biomarker for lung cancerTumour Biol2015363745–5010.1007/s13277-014-3014-625563194Open DOISearch in Google Scholar
Dodic Fikfak M, Kriebel D, Quinn MM, Eisen EA, Wegman DH. A case control study of lung cancer and exposure to chrysotile and amphibole at a slovenian asbestos-cement plant. Ann Occup Hyg 2007; 51: 261-8. doi: 10.1093/annhyg/mem003DodicFikfak MKriebelDQuinnMMEisenEAWegmanDHA case control study of lung cancer and exposure to chrysotile and amphibole at a slovenian asbestos-cement plantAnn Occup Hyg200751261–810.1093/annhyg/mem00317351264Open DOISearch in Google Scholar
Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960; 17: 260-71.WagnerJCSleggsCAMarchandPDiffuse pleural mesothelioma and asbestos exposure in the North Western Cape ProvinceBr J Ind Med196017260–7110.1136/oem.17.4.260103807813782506Search in Google Scholar
Muscat JE, Wynder EL. Cigarette smoking, asbestos exposure, and malignant mesothelioma. Cancer Res 1991; 51: 2263-7.MuscatJEWynderELCigarette smoking, asbestos exposure, and malignant mesotheliomaCancer Res1991512263–7Search in Google Scholar
Berry G, Newhouse ML, Antonis P. Combined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workers. Br J Ind Med 1985; 42: 12-8.BerryGNewhouseMLAntonisPCombined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workersBr J Ind Med19854212–810.1136/oem.42.1.1210074103965010Search in Google Scholar
Lacourt A, Leveque E, Guichard E, Gilg Soit Ilg A, Sylvestre MP, Leffondre K. Dose-time-response association between occupational asbestos exposure and pleural mesothelioma. Occup Environ Med 2017; 74: 691-7. doi: 10.1136/oemed-2016-104133LacourtALevequeEGuichardEGilgSoit Ilg ASylvestreMPLeffondreKDose-time-response association between occupational asbestos exposure and pleural mesotheliomaOccup Environ Med201774691–710.1136/oemed-2016-10413328501798Open DOISearch in Google Scholar
Ulvestad B, Kjaerheim K, Martinsen JI, Damberg G, Wannag A, Mowe G, et al. Cancer incidence among workers in the asbestos-cement producing industry in Norway. Scand J Work Environ Health 2002; 28: 411-7. doi: 10.5271/sjweh.693UlvestadBKjaerheimKMartinsenJIDambergGWannagAMoweGet alCancer incidence among workers in the asbestos-cement producing industry in NorwayScand J Work Environ Health200228411–710.5271/sjweh.69312539801Open DOISearch in Google Scholar
